VCBeat Health Contact Us
Home Everest Medicines Partners with Vcare Pharma; GSK Acquires Nuvalent for $10.6B; J&J Spends $1B on KRAS

Everest Medicines Partners with Vcare Pharma; GSK Acquires Nuvalent for $10.6B; J&J Spends $1B on KRAS

Jun 09, 2026 19:25 CST Updated Jun 10, 13:53
Everest Medicines

Developer of Innovative Therapies

GSK

Pharmaceutical R&D Manufacturer

Nuvalent

Targeted Therapy Drug Developer